Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

NCT00068081 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
150
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

NeurogesX